Department of Pharmaceutical Technology, Faculty of Pharmacy, National and Kapodistrian University of Athens, Athens, Greece.
Pathologist, Parodos Efthalias Adam, Serres, Greece.
Skin Pharmacol Physiol. 2018;31(4):175-183. doi: 10.1159/000487404. Epub 2018 Apr 4.
BACKGROUND/AIMS: There is no treatment, without side effects, efficiently preventing or curing skin burns, caused by radiotherapy. A new experimental topical treatment protocol was assessed in mice receiving orthovoltage X-rays at an equivalent dose to that applied to human breast cancer patients in conventional radiotherapy.
SKH-HR2 female hairless mice were irradiated on their dorsum with a total dose of 4,300 cGy during a 1-month period (20 fractions). The treatment group received a combination of 3 topical products, an oil-in-water cream, a gel containing Pinus halepensis bark aqueous extract, and an ointment containing olive oil extract of the marine isopod Ceratothoa oestroides. The positive control group was treated with a conventionally used commercial gel, whereas the negative control group did not receive any topical treatment. Skin alterations were evaluated by macroscopic examinations, measurements of transepidermal water loss (TEWL), melanin content, erythema intensity, hydration, and histopathology assessment.
Sixty days after radiation, TEWL and hydration values were abnormal and elements of acute, chronic, and granulomatous inflammation were present in all cases. The severest damage was detected in the deeper dermis. Treatment showed a comparatively beneficial effect on chronic and granulomatous inflammation while positive control was beneficial on acute inflammation.
Skin anti-inflammatory treatment was the most effective but must be applied for several months. Further preclinical studies should be conducted, assimilating a human cancer radiation therapeutic schema with the aim of optimizing skin inflammation treatment.
背景/目的:目前尚无治疗方法,既能有效预防或治疗放疗引起的皮肤灼伤,又无副作用。本研究评估了一种新的实验性局部治疗方案,该方案应用于接受正交 X 射线照射的小鼠,照射剂量相当于常规放疗中应用于人类乳腺癌患者的剂量。
将 SKH-HR2 无毛雌性小鼠背部接受总剂量为 4300cGy 的照射,照射时间为 1 个月(20 次)。治疗组接受 3 种局部产品的联合治疗,即油包水乳膏、含有欧洲赤松树皮水提物的凝胶和含有 Ceratothoa oestroides 海洋等足目提取物的软膏。阳性对照组接受常规市售凝胶治疗,阴性对照组不接受任何局部治疗。通过肉眼观察、经表皮水分流失(TEWL)测量、黑色素含量、红斑强度、皮肤水合作用和组织病理学评估来评估皮肤变化。
放射后 60 天,TEWL 和皮肤水合作用值异常,所有病例均存在急性、慢性和肉芽肿性炎症的元素。真皮深层的损伤最严重。治疗组对慢性和肉芽肿性炎症有较好的疗效,而阳性对照组对急性炎症有较好的疗效。
皮肤抗炎治疗最有效,但需连续治疗数月。应进行进一步的临床前研究,将人类癌症放射治疗方案与优化皮肤炎症治疗的目标相结合。